NexGenEsis Healthcare

Franchise Overview

NexGenEsis Healthcare operates brick-and-mortar clinics delivering non-surgical, non-opioid pain relief and injury rehabilitation, using advanced regenerative therapy techniques to treat nerve and joint conditions as a drug-free alternative to traditional pain management.

Key Highlights

Drug-free, non-surgical regenerative therapy addressing a fast-growing patient demand
Structured franchisor systems cover both clinical and operational aspects seamlessly
Specialized medical training through an approved vendor ensures clinical consistency and compliance
Early-stage expansion offers ground-floor positioning in the regenerative medicine sector

NexGenEsis Healthcare provides franchisees with an established brand framework and proven systems, allowing operators to focus on delivering innovative patient care in a rapidly expanding healthcare niche.

Just the Facts

For most current information, see Franchise Disclosure Documents

In Business Since2019

Number of Units14

Min Liquid Capital—

Required Networth—

$$$Total Investment$125K – $1.8M

NexGenEsis Healthcare Franchise Disclosure Documents (FDD)

These official NexGenEsis Healthcare FDDs contain 23 sections of federally mandated disclosures such as franchisee obligations, franchisor litigation, and financial performance. FDD's are typically 100+ pages long and are critical to evaluate when researching a franchise.

Available Documents

NexGenEsis Healthcare FDD 2025

April 2025

$99.00

NexGenEsis Healthcare FDD 2024

May 2024

$99.00

NexGenEsis Healthcare FDD 2023

March 2023

$99.00

NexGenEsis Healthcare FDD 2022

September 2022

$99.00

Note: Purchased FDDs are available for immediate download. The $99 Document Processing Fee covers acquisition, storage, organization, and digital delivery of the FDD document.

Search for more FDDs